Le Lézard
Classified in: Health
Subjects: CCA, SLS

Capio to Publish Interim Report on October 27, 2017

GOTHENBURG, Sweden, Oct. 6, 2017 /PRNewswire/ -- Capio AB will publish the interim report for January-September 2017 on Friday, October 27 at approximately 08.00 am (CET).

08.00 am (approximately)

Report release. The report will be sent as a press release and will be published on Capio's website www.capio.com.

09.30 am Telephone conference and audio cast

Investors, analysts and media are invited to participate in a telephone conference at 09.30 am (CET).

President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions (in English).

The telephone conference will be audio casted live on www.capio.com.

To participate in the telephone conference, please register at www.capio.com and dial in five minutes prior to the start of the conference call.

Sweden: +46-8-566-426-93 UK: +44-203-008-98-04 US: +1-855-753-22-37 Finland: +35-898-171-04-93 France: +33-170-75-07-12

Prior to the start of the telephone conference, presentation slides will be available at www.capio.com.

A recorded version of the audio cast will be made available at


during the afternoon (CET).

Subscribe to press releases and financial information

To receive press releases and financial reports from Capio, please subscribe at www.capio.com/subscribe.

For information, please contact:
Olof Bengtsson
Telephone: +46-761-18-74-69

Kristina Ekeblad
IR manager
Telephone: +46-708-31-19-40

This information was brought to you by Cision http://news.cision.com


The following files are available for download:



These press releases may also interest you

at 04:00
WASHINGTON, Oct. 19, 2017 /PRNewswire/ -- According to The International Trade Association, the global medical device, technology and equipment market is growing from $360 B to $450 B in 2018. While there's tremendous opportunity for startups and...

at 04:00
DURHAM, North Carolina, Oct. 19, 2017 /PRNewswire/ -- Alcami Corporation, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces the launch of its international...

at 04:00
ZURICH, October 19, 2017 /PRNewswire/ -- Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that it will have a poster presentation at the upcoming...

at 04:00
TraceLink, Sharp and Major Pharma Brand to Discuss Trade Partner Connectivity at CPhI Worldwide NORTH READING, Massachusetts, Oct. 19, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life...

at 03:00
LUGANO, Switzerland, October 19, 2017 /PRNewswire/ -- ESMO, the leading professional organisation for medical oncology, has granted the newly established ESMO Award for Immuno-Oncology to Prof Laurence Zitvogel for her innovating and internationally...

at 02:16
UPPSALA, Sweden, Oct.19, 2017 /PRNewswire/ -- Financial overview Q3 2017 Total net revenues SEK 166.2 million (181.9) Zubsolv® US net revenue SEK 121.1 million (142.4) EBIT SEK 40.9 million (43.0) EBITDA SEK 46.1 million (50.9) Earnings per...

News published on 6 october 2017 at 03:32 and distributed by: